Monday Plan: Hold the Growth Anchor as Iran Escalation and AI Rotation Pressure
the Open
Portfolio frozen through the weekend at LLY 27%, META 23%, JPM 20%, NVDA 17%, AMZN 13%. US-Iran military escalation — two service members killed in Jordan, Iran threatening response after calling off an interim peace deal — introduces a genuine geopolitical risk premium into Monday's open. LLY's 60-day momentum has improved to 9.44%, the strongest in the candidate universe, positioning the book's quality anchor well for a risk-off open within growth. META and NVDA face near-term AI rotation and White House frontier AI access headwinds, but the Blackwell and Llama infrastructure theses remain intact ahead of Q2 earnings. NVDA's 60-day has crossed the -2% monitoring threshold at -2.95%; the second exit condition — a credible hyperscaler order revision — remains inactive.
The prior plan positioned LLY as the defensive quality anchor and META as the dominant momentum driver into Friday. LLY delivered precisely on that framing with a +0.85% session — the sole positive contributor in the book — but concentrated internet and semiconductor exposure pulled the book to -1.05% against SPY's -0.99%, a 6bp underperformance. The LLY call and the AMZN and JPM trims were directionally correct; the META upgrade to 23% ahead of the AI rotation narrative proved costly on the day.
Since Last Session
Friday, July 17 closed with the book returning -1.05% against SPY's -0.99%. The 6bp underperformance was driven by the book's concentration in internet and semiconductor names at a moment when the broad market rotated toward energy and quality-defensive healthcare.
LLY was the sole positive contributor, returning +0.85% on a 27% weight. META was the largest single drag at -2.79% on 23% weight, followed by NVDA at -2.21% on 17% weight. AMZN declined -1.06% on 13% weight and JPM fell -0.60% on 20% weight. Energy outperformed broadly on Friday, but the book carries no direct energy exposure. VIX closed at 18.77, up meaningfully from the 16.73 reading that framed the prior report, marking a step-up in perceived risk that is now the baseline entering Monday.
Plan for Monday
This journal is written on Sunday, July 19. No session is open and the portfolio is unchanged from Friday's close. The plan described here takes effect at Monday's open.
The dominant event between Friday's close and this writing is the US-Iran military escalation: two US service members were killed in Jordan, one is missing, and Iran has threatened "unforgettable lessons" following the collapse of an interim peace deal. This is a qualitative shift in geopolitical risk — not routine diplomatic friction. A risk-off Monday open is the base case: energy names are likely to gap higher on supply-disruption concerns, gold may extend Friday's gains on safe-haven demand, and names with high AI-multiple exposures face additional headwinds on risk-appetite compression.
The framework here is not to respond to geopolitical risk by rotating into hedges or cash. The correct expression of caution is to let LLY's 27% weight function as the book's quality anchor — healthcare demand is structurally disconnected from geopolitical risk — while monitoring whether META and NVDA confirm or deepen the AI rotation pattern in the opening hour.
Two AI-specific signals from the weekend add texture to Monday's setup. First, post-market analysis noted that the AI rotation has overshadowed an otherwise strong start to earnings season. This is consistent with last week's tape: the market is differentiating within AI rather than exiting it, and the incumbents with the clearest earnings bridges — META via inference monetization, NVDA via Blackwell hardware absorption — are better positioned than narrative-driven plays. Second, the White House is reported to be actively shaping access to frontier AI models, shifting policy leverage away from independent labs. This is a near-term headwind for pure-play frontier model exposure but is not a direct input for META's proprietary Llama stack or NVDA's hardware business under current export policy.
What Monday must confirm before the full plan is affirmed: LLY continues to exhibit relative sector resilience as geopolitical risk drives quality-seeking within growth; META and NVDA do not see a second consecutive day of concentrated selling that breaks the 20-day momentum trend; and the Iran situation does not escalate to a level that sustains VIX above 25 or materially widens credit spreads.
Positioning
The book enters Monday at LLY 27%, META 23%, JPM 20%, NVDA 17%, and AMZN 13%. This is the same positioning that closed Friday and reflects the conviction hierarchy established over the prior three weeks: healthcare secular growth leads, mega-cap AI infrastructure follows, financials and cloud provide earnings-cycle participation.
LLY at 27% is the most defensible single decision in this regime. The 60-day has improved to 9.44% — the strongest in the candidate universe — and the Iran escalation is a directional tailwind for quality healthcare: investors seeking earnings durability without rate-duration or trade-policy exposure tend to consolidate in high-growth pharma with multi-year revenue visibility. The GLP-1 penetration curve is intact, no credible biosimilar competition has emerged, and the position has a demonstrated track record of outperforming in risk-off sessions within the current book.
META at 23% carries a near-term risk given the AI rotation narrative and the White House AI access announcement. The 60-day has compressed from 8.60% to 5.64%, leaving less momentum buffer for a downside surprise in Q2 earnings. However, the 20-day at 6.73% is the strongest near-term reading in the book, and the Llama infrastructure moat is not subject to government licensing in the same way frontier API models are. Q2 earnings in approximately two weeks are the primary validation event for this sizing.
NVDA at 17% has its 60-day at -2.95%, which crosses the monitoring threshold but does not meet the full exit condition — the second required signal, a credible hyperscaler order revision, has not materialized. The Blackwell absorption thesis remains the anchor; hyperscaler capex guidance in upcoming Q2 calls is the observable that matters, and nothing in the weekend news flow speaks to that directly.
JPM at 20% and AMZN at 13% hold their prior sizing. JPM's 60-day at 7.61% is moderating but remains the second-strongest reading in the book. AMZN's continued 60-day deterioration to -2.69% confirms 13% as the correct constraint-adjusted size until Q2 AWS results provide a re-rating catalyst.
Institutional Signals
Bridgewater's simultaneous SPY (12.7%), AMZN (4.1%), and NVDA (3.7%) holdings confirm a broad-exposure, growth-oriented framework that is not rotating defensively despite rate uncertainty. The posture is consistent with a regime that is uncertain on policy path but not bearish on AI infrastructure demand. Pershing Square's concentrated AMZN (17.4%) and MSFT (15.3%) positions signal that Ackman's team continues to weight cloud and enterprise software over pure hardware — a useful frame for sizing AMZN at 13% rather than trimming it further despite momentum headwinds. Berkshire's absence from the AI names in the top five is consistent with its characteristic technology lag and is not a contrary signal for this book. Scion's Burry holds 13.5% in NVDA alongside a 66% PLTR concentration — the NVDA position reflects hardware infrastructure conviction that is independent of the current AI rotation debate.
Collectively, the institutional filings reinforce a regime where AI infrastructure is real and earnings-backed, but where differentiation within the space is widening. This book's positioning — META and NVDA as infrastructure leads rather than frontier AI software — aligns with the Bridgewater and Pershing read.
What Could Break It
- Iran escalation materializes into a broader regional military conflict with an energy supply disruption serious enough to sustain VIX above 25 or materially widen credit spreads, at which point AI multiple compression would become a regime break rather than a sector rotation.
- White House AI access restrictions expand beyond frontier model licensing into semiconductor hardware export controls, creating a direct policy headwind for NVDA that activates the exit condition independent of the 60-day threshold.
- META Q2 advertising revenue miss or forward guidance cut that invalidates the inference monetization thesis embedded in the 23% sizing — the 60-day has already compressed from 8.60% to 5.64%, leaving less buffer for a downside surprise.
- LLY receives an adverse CMS GLP-1 reimbursement ruling or a credible tirzepatide biosimilar IND filing that breaks the secular growth narrative underlying the 27% overweight.
- NVDA 60-day deterioration continues and is accompanied by a credible hyperscaler order revision — only then does the full exit condition activate and a trim to 12-13% becomes warranted.